A scalable approach to prevent teratoma formation of human embryonic stem cells

Journal of Biological Chemistry

Volumn 287, Issue 39, 2012, Pages 32338-32345

  Rong, Zhili ^a   Fu, Xuemei ^a,b   Wang, Meiyan ^a   Xu, Yang ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b CHENGDU WOMEN S AND CHILDREN S CENTRAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RISK; CELL TYPES; DIFFERENTIATED CELLS; HERPES SIMPLEX VIRUS; HOMOLOGOUS RECOMBINATION; HUMAN CELLS; HUMAN EMBRYONIC STEM CELLS; HUMAN GENE THERAPY; PLURIPOTENCY; RENEWABLE SOURCES; SCALABLE APPROACH; THERAPEUTIC TARGETS; THYMIDINE KINASE; UNTRANSLATED REGIONS;

CYTOLOGY; DRUG THERAPY; ENZYMES; GENES; TUMORS; VIRUSES;

CELLS;

THYMIDINE KINASE; TRANSCRIPTION FACTOR NANOG;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RISK; CARCINOGENESIS; CELL DIFFERENTIATION; CELL RENEWAL; CELL THERAPY; CELL TYPE; CONTROLLED STUDY; DRUG TARGETING; EMBRYONIC STEM CELL; FOOD AND DRUG ADMINISTRATION; GENE THERAPY; GENETIC VARIABILITY; HERPES SIMPLEX VIRUS; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TERATOMA; VIRUS GENE;

ANIMALS; CELL DIFFERENTIATION; CELL LINE; EMBRYONIC STEM CELLS; GENES, TRANSGENIC, SUICIDE; HOMEODOMAIN PROTEINS; HUMANS; MICE; SIMPLEXVIRUS; TERATOMA; THYMIDINE KINASE; TISSUE THERAPY; VIRAL PROTEINS;

SIMPLEXVIRUS;

EID: 84866564584     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.383810     Document Type: Article

References (36)

1. Scadden, D., and Srivastava, A. (2012) Advancing stem cell biology toward stem cell therapeutics. Cell Stem Cell 10, 149-150
2. Singec, I., Jandial, R., Crain, A., Nikkhah, G., and Snyder, E. Y. (2007) The leading edge of stem cell therapeutics. Annu. Rev. Med. 58, 313-328 (Pubitemid 46706517)
3. Goldring, C. E., Duffy, P. A., Benvenisty, N., Andrews, P. W., Ben-David, U., Eakins, R., French, N., Hanley, N. A., Kelly, L., Kitteringham, N. R., Kurth, J., Ladenheim, D., Laverty, H., McBlane, J., Narayanan, G., Patel, S., Reinhardt, J., Rossi, A., Sharpe, M., and Park, B. K. (2011) Assessing the safety of stem cell therapeutics. Cell Stem Cell 8, 618-628
4. Ben-David, U., and Benvenisty, N. (2011) The tumorigenicity of human embryonic and induced pluripotent stem cells. Nat. Rev. Cancer 11, 268-277
5. Fong, C. Y., Gauthaman, K., and Bongso, A. (2010) Teratomas from pluripotent stem cells: A clinical hurdle. J. Cell. Biochem. 111, 769-781
6. Tan, H. L., Fong, W. J., Lee, E. H., Yap, M., and Choo, A. (2009) mAb 84, a mcytotoxic antibody that kills undifferentiated human embryonic stem cells via oncosis. Stem Cells 27, 1792-1801
7. Choo, A. B., Tan, H. L., Ang, S. N., Fong, W. J., Chin, A., Lo, J., Zheng, L., Hentze, H., Philp, R. J., Oh, S. K., and Yap, M. (2008) Selection against undifferentiated human embryonic stem cells by a cytotoxic antibody recognizing podocalyxin-like protein-1. Stem Cells 26, 1454-1463
8. Kershaw, D. B., Beck, S. G., Wharram, B. L., Wiggins, J. E., Goyal, M., Thomas, P. E., and Wiggins, R. C. (1997) Molecular cloning and characterization of human podocalyxin-like protein. Orthologous relationship to rabbit PCLP1 and rat podocalyxin. J. Biol. Chem. 272, 15708-15714 (Pubitemid 27265543)
9. Tang, C., Lee, A. S., Volkmer, J. P., Sahoo, D., Nag, D., Mosley, A. R., Inlay, M. A., Ardehali, R., Chavez, S. L., Pera, R. R., Behr, B., Wu, J. C., Weissman, I. L., and Drukker, M. (2011) An antibody against SSEA-5 glycan on human pluripotent stem cells enables removal of teratoma-forming cells. Nat. Biotechnol. 29, 829-834
10. Bradley, J. E., Ramirez, G., and Hagood, J. S. (2009) Roles and regulation of Thy-1, a context-dependent modulator of cell phenotype. BioFactors 35, 258-265
11. Horie, R., and Watanabe, T. (1998) CD30: Expression and function in health and disease. Semin. Immunol. 10, 457-470 (Pubitemid 28564375)
12. Rubinstein, E., Billard, M., Plaisance, S., Prenant, M., and Boucheix, C. (1993) Molecular cloning of the mouse equivalent of CD9 antigen. Thromb. Res. 71, 377-383 (Pubitemid 23244326)
13. Wright, G. J., Jones, M., Puklavec, M. J., Brown, M. H., and Barclay, A. N. (2001) The unusual distribution of the neuronal/lymphoid cell surface CD200 (OX2) glycoprotein is conserved in humans. Immunology 102, 173-179 (Pubitemid 32217509)
14. Fujikawa, T., Oh, S. H., Pi, L., Hatch, H. M., Shupe, T., and Petersen, B. E. (2005) Teratoma formation leads to failure of treatment for type I diabetes using embryonic stem cell-derived insulin-producing cells. Am. J. Pathol. 166, 1781-1791 (Pubitemid 40734401)
15. Shen, Y., and Nemunaitis, J. (2006) Herpes simplex virus 1 (HSV-1) for cancer treatment. Cancer Gene Ther. 13, 975-992 (Pubitemid 44564734)
16. Hara, A., Aoki, H., Taguchi, A., Niwa, M., Yamada, Y., Kunisada, T., and Mori, H. (2008) Neuron-like differentiation and selective ablation of undifferentiated embryonic stem cells containing suicide gene with Oct-4 promoter. Stem Cells Dev. 17, 619-627
17. Schuldiner, M., Itskovitz-Eldor, J., and Benvenisty, N. (2003) Selective ablation of human embryonic stem cells expressing a "suicide" gene. Stem Cells 21, 257-265 (Pubitemid 36623167)
18. Cheng, F., Ke, Q., Chen, F., Cai, B., Gao, Y., Ye, C., Wang, D., Zhang, L., Lahn, B. T., Li, W., and Xiang, A. P. (2012) Protecting against wayward human induced pluripotent stem cells with a suicide gene. Biomaterials 33, 3195-3204
19. Liedtke, S., Stephan, M., and Kögler, G. (2008) Oct4 expression revisited: Potential pitfalls for data misinterpretation in stem cell research. Biol. Chem. 389, 845-850
20. Mitsui, K., Tokuzawa, Y., Itoh, H., Segawa, K., Murakami, M., Takahashi, K., Maruyama, M., Maeda, M., and Yamanaka, S. (2003) The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113, 631-642 (Pubitemid 36694188)
21. Chambers, I., Colby, D., Robertson, M., Nichols, J., Lee, S., Tweedie, S., and Smith, A. (2003) Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113, 643-655 (Pubitemid 36694189)
22. Hart, A. H., Hartley, L., Parker, K., Ibrahim, M., Looijenga, L. H., Pauchnik, M., Chow, C. W., and Robb, L. (2005) The pluripotency homeobox gene NANOGis expressed in human germ cell tumors. Cancer 104, 2092-2098 (Pubitemid 41579954)
23. Arumugam, S. B., Trentz, O. A., Arikketh, D., Senthinathan, V., Rosario, B., and Mohandas, P. V. (2011) Detection of embryonic stem cell markers in adult human adipose tissue-derived stem cells. Indian J. Pathol. Microbiol. 54, 501-508
24. Kohler, E. E., Cowan, C. E., Chatterjee, I., Malik, A. B., and Wary, K. K. (2011)NANOGinduction of fetal liver kinase-1 (FLK1) transcription regulates endothelial cell proliferation and angiogenesis. Blood 117, 1761-1769
25. +, and SOX2- mesenchymal cells from peripheral blood of a diabetes mellitus patient. Hum. Cell 24, 51-55
26. Song, H., Chung, S. K., and Xu, Y. (2010) Modeling disease in human ESCs using an efficient BAC-based homologous recombination system. Cell Stem Cell 6, 80-89
27. Copeland, N. G., Jenkins, N. A., and Court, D. L. (2001) Recombineering: A powerful new tool for mouse functional genomics. Nat. Rev. Genet. 2, 769-779 (Pubitemid 33685574)
28. Song, H., Hollstein, M., and Xu, Y. (2007) p53 gain-of-function cancer mutants induce genetic instability by inactivating ATM. Nat. Cell Biol. 9, 573-580 (Pubitemid 46696539)
29. Liu, D., Ou, L., Clemenson, G. D., Jr., Chao, C., Lutske, M. E., Zambetti, G. P., Gage, F. H., and Xu, Y. (2010) Puma is required for p53-induced depletion of adult stem cells. Nat. Cell Biol. 12, 993-998
30. Hatano, S. Y., Tada, M., Kimura, H., Yamaguchi, S., Kono, T., Nakano, T., Suemori, H., Nakatsuji, N., and Tada, T. (2005) Pluripotential competence of cells associated with Nanog activity. Mech. Dev. 122, 67-79 (Pubitemid 39593746)
31. Black, M. E., Kokoris, M. S., and Sabo, P. (2001) Herpes simplex virus-1 thymidine kinase mutants created by semi-random sequence mutagenesis improve prodrug-mediated tumor cell killing. Cancer Res. 61, 3022-3026 (Pubitemid 32691949)
32. Serganova, I., Ponomarev, V., and Blasberg, R. (2007) Human reporter genes: Potential use in clinical studies. Nucl. Med. Biol. 34, 791-807 (Pubitemid 47503822)
33. Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., and Jones, J. M. (1998) Embryonic stem cell lines derived from human blastocysts. Science 282, 1145-1147 (Pubitemid 28516247)
34. Fu, X., and Xu, Y. (2011) Self-renewal and scalability of human embryonic stem cells for human therapy. Regen. Med. 6, 327-334
35. McGavin, J. K., and Goa, K. L. (2001) Ganciclovir: An update of its use in the prevention of cytomegalovirus infection and disease in transplant recipients. Drugs 61, 1153-1183 (Pubitemid 32661232)
36. Howden, S. E., Gore, A., Li, Z., Fung, H. L., Nisler, B. S., Nie, J., Chen, G., McIntosh, B. E., Gulbranson, D. R., Diol, N. R., Taapken, S. M., Vereide, D. T., Montgomery, K. D., Zhang, K., Gamm, D. M., and Thomson, J. A. (2011) Genetic correction and analysis of induced pluripotent stem cells from a patient with gyrate atrophy. Proc. Natl. Acad. Sci. U.S.A. 108, 6537-6542